IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial ...
Zacks Investment Research on MSN
Will Beta Bionics, Inc. (BBNX) report negative earnings next week? What you should know
The market expects Beta Bionics, Inc. (BBNX) to deliver a year-over-year increase in earnings on higher revenues when it ...
Beta Bionics (NASDAQ:BBNX) reported fourth-quarter and full-year 2025 results on its earnings call Tuesday, highlighting ...
Analysts estimate that Beta Bionics will report an earnings per share (EPS) of $-0.39. Beta Bionics bulls will hope to hear ...
The consensus estimate for Q4 2025 revenue is $0.03 billion, and the earnings are expected to come in at -$0.42 per share. The full year 2025's revenue is expected to be $0.10 billion, and the ...
IRVINE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management ...
Zacks Investment Research on MSN
Beta Bionics, Inc. (BBNX) reports Q4 loss, tops revenue estimates
Beta Bionics, Inc. (BBNX) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to a loss of $1.82 per share a year ago. These figures ...
Patch pump under development with commercialization expected by the end of 2027 One of Orange County’s fastest-growing public companies only went public two months ago. Beta Bionics Inc.’s concept of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results